Skip to main content
Production in Australia)

PRODUCTS

OUR PRODUCTS

This information is intended for U.S. residents.

Here you will find a listing of our products available in the U.S.

Consumers should contact their healthcare professional for further advice.

AFLURIA® TRIVALENT, Influenza Vaccine Suspension for Intramuscular Injection 

AFLURIA® TRIVALENT is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. AFLURIA TRIVALENT is approved for use in persons 6 months of age and older

MORE INFORMATION
 
FLUAD® TRIVALENT (Influenza Vaccine, Adjuvanted) Suspension for Intramuscular Injection 

FLUAD TRIVALENTis an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine. FLUAD TRIVALENT is approved for use in persons 65 years of age and older. Approval is based on the immune response elicited by FLUAD TRIVALENT. Data demonstrating a decrease in influenza disease after vaccination with FLUAD TRIVALENT are not available.

MORE INFORMATION
FLUCELVAX® TRIVALENT (Influenza Vaccine) Suspension for Intramuscular Injection 

FLUCELVAX TRIVALENT is an inactivated vaccine indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine. FLUCELVAX TRIVALENT is approved for use in persons 6 months of age and older.

MORE INFORMATION

The trademarks marked ® are registered by CSL Seqirus U.K. Limited or its affiliates in one or more jurisdictions, unless indicated otherwise.

For more information about our products:

If you are a healthcare professional, please click here.

Medical Information Portal for Healthcare Providers: https://medinfo.seqirus.com/

Pandemic Response Solutions

As a global leader in influenza vaccine manufacturing, CSL Seqirus offers a portfolio of pandemic vaccines and services which are tailored to rapid response.
Learn more

 

Important Safety Information for AFLURIA

Consumer

What is AFLURIA® (Influenza Vaccine)?

AFLURIA is a vaccine that helps protect people aged 6 months and older from the flu. Vaccination with AFLURIA may not protect all people who receive the vaccine.

Who should not receive AFLURIA?

You should not receive AFLURIA if you have a history of severe allergic reactions (e.g., anaphylaxis) to any component of the vaccine including egg protein, or to a previous dose of any influenza vaccine.

Before receiving AFLURIA, tell your healthcare provider about all medical conditions, including if you:

  • have ever had Guillain-Barré syndrome (severe muscle weakness) within six weeks after getting a flu vaccine. The decision to give AFLURIA should be made by your healthcare provider, based on careful consideration of the potential benefits and risks.
  • have problems with your immune system or are taking certain medications that suppress your immune system, as these may reduce your immune response to the vaccine

What are the most common side effects of AFLURIA?

  • pain, tenderness, redness, itching, bruising, and/or swelling where the vaccine was given
  • headache
  • muscle aches
  • feeling unwell (malaise)

Additional side effects seen in children include:

  • irritability
  • diarrhea
  • loss of appetite
  • extreme tiredness

These are not all the possible side effects of AFLURIA. You can ask your healthcare provider for more information and for advice about any side effects that concern you.

What do I do if I have side effects?

Report any severe or unusual side effects to your healthcare provider.

To report SUSPECTED ADVERSE REACTIONS, contact CSL Seqirus at 1-855-358-8966 or VAERS at 1-800-822-7967 or www.vaers.hhs.gov.

Before receiving this vaccine, please see the full prescribing information for AFLURIA. You can ask your healthcare provider or pharmacist for information about AFLURIA that is written for healthcare professionals.

Important Safety Information for FLUAD

Consumer

What is FLUAD® (Influenza Vaccine, Adjuvanted)?

FLUAD is a vaccine that helps protect people aged 65 years and older from the flu.Vaccination with FLUAD may not protect all people who receive the vaccine.

Who should not recieve FLUAD?

You should not receive FLUAD if you have a history of severe allergic reactions (e.g.,anaphylaxis) to any component of the vaccine, including egg protein, or to a previous influenza vaccine.

Before receiving FLUAD, tell your healthcare provider about all medical conditions, including if you:

  • Have ever had Guillain-Barré syndrome (severe muscle weakness) within six weeks after getting a flu vaccine. The decision to give FLUAD should be made by your healthcare provider, based on careful consideration of the potential benefits and risks.
  • have problems with your immune system or are taking certain medications that suppress your immune system, as these may reduce your immune response to the vaccine
  • have ever fainted when receiving a vaccine

What are the most common side effects of FLUAD?

  • Pain and tenderness where vaccine was given
  • Muscle ache
  • Tiredness
  • Headache

These are not all the possible side effects of FLUAD. You can ask your healthcare provider for more information and for advice about any side effects that concern you.

What do I do if I have side effects?

Report any severe or unsual side effects to your healthcare provider.

To report SUSPECTED ADVERSE REACTIONS, contact CSL Seqirus at 1-855-358-8966 or VAERS at 1-800-822-7967 and www.vaers.hhs.gov.

Before receiving this vaccine, please see the full Prescribing Information for FLUAD. You can ask your healthcare provider or pharmacist for information about FLUAD that is written for healthcare professionals.

Important Safety Information for FLUCELVAX

Consumer

What is FLUCELVAX® (Influenza Vaccine)?

FLUCELVAX is a vaccine that helps protect people aged 6 months and older from the flu. Vaccination with FLUCELVAX may not protect all people who receive the vaccine.

Who should not receive FLUCELVAX?

You should not receive FLUCELVAX if you have had a severe allergic reactions (e.g., anaphylaxis) to any component of the vaccine.

Before receiving FLUCELVAX, tell your healthcare provider about all medical conditions, including if you:

  • have ever had Guillain-Barré Syndrome (severe muscle weakness) within six weeks after getting a flu vaccine. The decision to give FLUCELVAX should be made by your healthcare provider, based on careful consideration of the potential benefits and risks.
  • have problems with your immune system or are taking certain medications that suppress your immune system, as these may reduce your immune response to the vaccine
  • have ever fainted when receiving a vaccine

What are the most common side effects of FLUCELVAX?

  • pain and/or redness where the vaccine was given
  • headache
  • extreme tiredness
  • muscle aches

Additional side effects seen in children include:

  • tenderness, bruising and/or a raised hardened area where the vaccine was given
  • sleepiness
  • irritability
  • diarrhea
  • changes in eating habits
  • feeling unwell (malaise)

These are not all of the possible side effects of FLUCELVAX. You can ask your healthcare provider for more information and for advice about any side effects that concern you.

What do I do if I have side effects?. Report any severe or unusual side effects to your healthcare provider.

To report SUSPECTED ADVERSE REACTIONS, contact CSL Seqirus at 1-855-358-8966 or VAERS at 1-800-822-7967 or www.vaers.hhs.gov.

Before receiving this vaccine, please see the full US Prescribing Information for FLUCELVAX. You can ask your healthcare provider or pharmacist for information about FLUCELVAX that is written for healthcare professionals

US/CORP/0919/0170